| 73 Treffer |
| ART-NR | PRODUKT | HERSTELLER | MENGE | PREIS |
| Cay60401-1 |
5-Lipoxygenase (potato) Screening Enzyme 5-LO inhibitor Contains purified potato 5-lipoxygenase (5-LO) supplied in 0.1 M Tris-HCl (pH 7.4) containing 0.1% BSA. 5-LO has been formulated to be used for screening 5-LO specific inhibitors using the Lipoxygenase Inhibitor Screening Assay (Catalog No. 760700). |
Cayman |
1 each |
74 €
|
| Cay10004161-100 |
CAS: 491-70-3 15-LO inhibitor Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM. MW: 286 D Formula: C15H10O6 Purity: >98% |
Cayman |
100 mg |
111 €
|
| Cay10004161-50 |
CAS: 491-70-3 15-LO inhibitor Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM. MW: 286 D Formula: C15H10O6 Purity: >98% |
Cayman |
50 mg |
63 €
|
| Cay10004161-500 |
CAS: 491-70-3 15-LO inhibitor Luteolin is one of the most potent flavanoid inhibitors of soybean and reticulocyte 15-lipoxygenases, with an IC50 of 0.6 µM. MW: 286 D Formula: C15H10O6 Purity: >98% |
Cayman |
500 mg |
487 €
|
| Cay10006967-10 |
CAS: 111406-87-2 5-LO inhibitor There is substantial evidence that the cysteinyl-leukotrienes (cysLTs), such as LTC4, LTD4, and LTE4, play an important role in the pathophysiology of asthma. Arachidonic acid is the precursor fatty acid that is transformed into LTs by way of the 5-lipoxy ... mehr MW: 236 D Formula: C11H12N2O2S Purity: >98% |
Cayman |
10 mg |
35 €
|
| Cay10006967-25 |
CAS: 111406-87-2 5-LO inhibitor There is substantial evidence that the cysteinyl-leukotrienes (cysLTs), such as LTC4, LTD4, and LTE4, play an important role in the pathophysiology of asthma. Arachidonic acid is the precursor fatty acid that is transformed into LTs by way of the 5-lipoxy ... mehr MW: 236 D Formula: C11H12N2O2S Purity: >98% |
Cayman |
25 mg |
84 €
|
| Cay10006967-5 |
CAS: 111406-87-2 5-LO inhibitor There is substantial evidence that the cysteinyl-leukotrienes (cysLTs), such as LTC4, LTD4, and LTE4, play an important role in the pathophysiology of asthma. Arachidonic acid is the precursor fatty acid that is transformed into LTs by way of the 5-lipoxy ... mehr MW: 236 D Formula: C11H12N2O2S Purity: >98% |
Cayman |
5 mg |
19 €
|
| Cay10006967-50 |
CAS: 111406-87-2 5-LO inhibitor There is substantial evidence that the cysteinyl-leukotrienes (cysLTs), such as LTC4, LTD4, and LTE4, play an important role in the pathophysiology of asthma. Arachidonic acid is the precursor fatty acid that is transformed into LTs by way of the 5-lipoxy ... mehr MW: 236 D Formula: C11H12N2O2S Purity: >98% |
Cayman |
50 mg |
148 €
|
| Cay10007692-1 |
CAS: 156897-06-2 COX inhibitor, LO inhibitor Licofelone is a dual inhibitor of cyclooxygenase (COX) and lipoxygenase (LO) pathways, that decreases levels of prostaglandin E2, leukotriene B4, and lipoxins and prevents lipopolysaccharide-stimulated IL-1beta expression. The IC50 values for inhibition o ... mehr MW: 379 D Formula: C23H22ClNO2 Purity: >98% |
Cayman |
1 mg |
50 €
|
| Cay10007692-10 |
CAS: 156897-06-2 COX inhibitor, LO inhibitor Licofelone is a dual inhibitor of cyclooxygenase (COX) and lipoxygenase (LO) pathways, that decreases levels of prostaglandin E2, leukotriene B4, and lipoxins and prevents lipopolysaccharide-stimulated IL-1beta expression. The IC50 values for inhibition o ... mehr MW: 379 D Formula: C23H22ClNO2 Purity: >98% |
Cayman |
10 mg |
399 €
|
| Cay10007692-5 |
CAS: 156897-06-2 COX inhibitor, LO inhibitor Licofelone is a dual inhibitor of cyclooxygenase (COX) and lipoxygenase (LO) pathways, that decreases levels of prostaglandin E2, leukotriene B4, and lipoxins and prevents lipopolysaccharide-stimulated IL-1beta expression. The IC50 values for inhibition o ... mehr MW: 379 D Formula: C23H22ClNO2 Purity: >98% |
Cayman |
5 mg |
225 €
|
| Cay10007692-50 |
CAS: 156897-06-2 COX inhibitor, LO inhibitor Licofelone is a dual inhibitor of cyclooxygenase (COX) and lipoxygenase (LO) pathways, that decreases levels of prostaglandin E2, leukotriene B4, and lipoxins and prevents lipopolysaccharide-stimulated IL-1beta expression. The IC50 values for inhibition o ... mehr MW: 379 D Formula: C23H22ClNO2 Purity: >98% |
Cayman |
50 mg |
1746 €
|
| Cay10007900-1 |
CAS: 34262-64-1 COX inhibitor, 12-LO inhibitor, 5-LO inhibitor 8,11,14-Eicosatriynoic acid inhibits cyclooxygenase (IC50 = 14 µM), human 12-lipoxygenase (IC50 = 0.46 µM), 5-lipoxygenase (IC50 = 25 µM) and the actions of slow-reacting substance of anaphylaxis (SRS-A) (IC50 = 10 µM). MW: 300 D Formula: C20H28O2 Purity: >98% |
Cayman |
1 mg |
77 €
|
| Cay10007900-10 |
CAS: 34262-64-1 COX inhibitor, 12-LO inhibitor, 5-LO inhibitor 8,11,14-Eicosatriynoic acid inhibits cyclooxygenase (IC50 = 14 µM), human 12-lipoxygenase (IC50 = 0.46 µM), 5-lipoxygenase (IC50 = 25 µM) and the actions of slow-reacting substance of anaphylaxis (SRS-A) (IC50 = 10 µM). MW: 300 D Formula: C20H28O2 Purity: >98% |
Cayman |
10 mg |
612 €
|
| Cay10007900-5 |
CAS: 34262-64-1 COX inhibitor, 12-LO inhibitor, 5-LO inhibitor 8,11,14-Eicosatriynoic acid inhibits cyclooxygenase (IC50 = 14 µM), human 12-lipoxygenase (IC50 = 0.46 µM), 5-lipoxygenase (IC50 = 25 µM) and the actions of slow-reacting substance of anaphylaxis (SRS-A) (IC50 = 10 µM). MW: 300 D Formula: C20H28O2 Purity: >98% |
Cayman |
5 mg |
345 €
|
| Cay10007900-50 |
CAS: 34262-64-1 COX inhibitor, 12-LO inhibitor, 5-LO inhibitor 8,11,14-Eicosatriynoic acid inhibits cyclooxygenase (IC50 = 14 µM), human 12-lipoxygenase (IC50 = 0.46 µM), 5-lipoxygenase (IC50 = 25 µM) and the actions of slow-reacting substance of anaphylaxis (SRS-A) (IC50 = 10 µM). MW: 300 D Formula: C20H28O2 Purity: >98% |
Cayman |
50 mg |
2680 €
|
| Cay10010468-10 |
CAS: 928853-86-5 15-LO inhibitor 15-LO inhibitor 1 is a heterocyclic pyrimidobenzothiazine compound that inhibits 15-LO with an IC50 value of 18 µM. The inhibitor appears to act as an antioxidant, interfering with the redox cycle of 15-LO. MW: 313 D Formula: C16H19N5S Purity: >98% |
Cayman |
10 mg |
357 €
|
| Cay10010468-5 |
CAS: 928853-86-5 15-LO inhibitor 15-LO inhibitor 1 is a heterocyclic pyrimidobenzothiazine compound that inhibits 15-LO with an IC50 value of 18 µM. The inhibitor appears to act as an antioxidant, interfering with the redox cycle of 15-LO. MW: 313 D Formula: C16H19N5S Purity: >98% |
Cayman |
5 mg |
199 €
|
| Cay10010518-10 |
CAS: 4079-26-9 15-LO inhibitor PD 146176 is a potent and selective inhibitor of reticulocyte 15-lipoxygenase-1. MW: 237 D Formula: C15H11NS Purity: >98% |
Cayman |
10 mg |
84 €
|
| Cay10010518-25 |
CAS: 4079-26-9 15-LO inhibitor PD 146176 is a potent and selective inhibitor of reticulocyte 15-lipoxygenase-1. MW: 237 D Formula: C15H11NS Purity: >98% |
Cayman |
25 mg |
198 €
|
| Cay10010518-50 |
CAS: 4079-26-9 15-LO inhibitor PD 146176 is a potent and selective inhibitor of reticulocyte 15-lipoxygenase-1. MW: 237 D Formula: C15H11NS Purity: >98% |
Cayman |
50 mg |
353 €
|
| Cay13271-10 |
CAS: 1051931-39-5 COX inhibitor, 5-LO inhibitor ZLJ-6 is a dual inhibitor of cyclooxygenase and 5-lipoxygenase . It reduces carrageenin-induced paw edema (inflammation) in rats and acetic acid-induced abdominal constriction (pain) in mice without causing gastrointestinal ulcers. MW: 375 D Formula: C12H13N3O3S ? CH3SO3H Purity: >98% |
Cayman |
10 mg |
288 €
|
| Cay13271-25 |
CAS: 1051931-39-5 COX inhibitor, 5-LO inhibitor ZLJ-6 is a dual inhibitor of cyclooxygenase and 5-lipoxygenase . It reduces carrageenin-induced paw edema (inflammation) in rats and acetic acid-induced abdominal constriction (pain) in mice without causing gastrointestinal ulcers. MW: 375 D Formula: C12H13N3O3S ? CH3SO3H Purity: >98% |
Cayman |
25 mg |
630 €
|
| Cay13271-5 |
CAS: 1051931-39-5 COX inhibitor, 5-LO inhibitor ZLJ-6 is a dual inhibitor of cyclooxygenase and 5-lipoxygenase . It reduces carrageenin-induced paw edema (inflammation) in rats and acetic acid-induced abdominal constriction (pain) in mice without causing gastrointestinal ulcers. MW: 375 D Formula: C12H13N3O3S ? CH3SO3H Purity: >98% |
Cayman |
5 mg |
162 €
|
| Cay13285-10 |
CAS: 1242-67-7 15-LO inhibitor CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO. It does not inhibit 5-LO effectively. MW: 342 D Formula: C23H34O2 Purity: >98% |
Cayman |
10 mg |
232 €
|
| Cay13285-5 |
CAS: 1242-67-7 15-LO inhibitor CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO. It does not inhibit 5-LO effectively. MW: 342 D Formula: C23H34O2 Purity: >98% |
Cayman |
5 mg |
131 €
|
| Cay13285-50 |
CAS: 1242-67-7 15-LO inhibitor CBDD is a cannabidiol derivative that potently and selectively inhibits 15-LO. It does not inhibit 5-LO effectively. MW: 342 D Formula: C23H34O2 Purity: >98% |
Cayman |
50 mg |
1015 €
|
| Cay13381-1 |
CAS: 1159576-98-3 5-LO inhibitor CAY10606 is a potent, reversible inhibitor of 5-LO, both in cell-free assays (IC50 = 86 nM) and in intact neutrophils (IC50 = 230 nM). It prevents the production of LTs in whole blood, whether 5-LO is activated with the calcium ionophore A23187 (IC50 = 1 ... mehr MW: 379 D Formula: C22H18ClNO3 Purity: >98% |
Cayman |
1 mg |
57 €
|
| Cay13381-10 |
CAS: 1159576-98-3 5-LO inhibitor CAY10606 is a potent, reversible inhibitor of 5-LO, both in cell-free assays (IC50 = 86 nM) and in intact neutrophils (IC50 = 230 nM). It prevents the production of LTs in whole blood, whether 5-LO is activated with the calcium ionophore A23187 (IC50 = 1 ... mehr MW: 379 D Formula: C22H18ClNO3 Purity: >98% |
Cayman |
10 mg |
455 €
|
| Cay13381-25 |
CAS: 1159576-98-3 5-LO inhibitor CAY10606 is a potent, reversible inhibitor of 5-LO, both in cell-free assays (IC50 = 86 nM) and in intact neutrophils (IC50 = 230 nM). It prevents the production of LTs in whole blood, whether 5-LO is activated with the calcium ionophore A23187 (IC50 = 1 ... mehr MW: 379 D Formula: C22H18ClNO3 Purity: >98% |
Cayman |
25 mg |
1732 €
|
| Cay13381-5 |
CAS: 1159576-98-3 5-LO inhibitor CAY10606 is a potent, reversible inhibitor of 5-LO, both in cell-free assays (IC50 = 86 nM) and in intact neutrophils (IC50 = 230 nM). It prevents the production of LTs in whole blood, whether 5-LO is activated with the calcium ionophore A23187 (IC50 = 1 ... mehr MW: 379 D Formula: C22H18ClNO3 Purity: >98% |
Cayman |
5 mg |
256 €
|
| Cay13665-1 |
CAS: 916482-17-2 mPGES-1 / 5-LO inhibitor YS121 is a dual inhibitor of microsomal prostaglandin E2 synthase-1 (mPGES-1) (IC50 = 3.9 µM) and 5-LO (IC50 = 4.1 µM). It effectively inhibits PGE2 and LT synthesis in both cell free and intact cell assays. Moreover, YS121 (1.5 kg/mg, intraperitoneal) ... mehr MW: 408 D Formula: C20H26ClN3O2S Purity: >98% |
Cayman |
1 mg |
50 €
|
| Cay13665-10 |
CAS: 916482-17-2 mPGES-1 / 5-LO inhibitor YS121 is a dual inhibitor of microsomal prostaglandin E2 synthase-1 (mPGES-1) (IC50 = 3.9 µM) and 5-LO (IC50 = 4.1 µM). It effectively inhibits PGE2 and LT synthesis in both cell free and intact cell assays. Moreover, YS121 (1.5 kg/mg, intraperitoneal) ... mehr MW: 408 D Formula: C20H26ClN3O2S Purity: >98% |
Cayman |
10 mg |
399 €
|
| Cay13665-25 |
CAS: 916482-17-2 mPGES-1 / 5-LO inhibitor YS121 is a dual inhibitor of microsomal prostaglandin E2 synthase-1 (mPGES-1) (IC50 = 3.9 µM) and 5-LO (IC50 = 4.1 µM). It effectively inhibits PGE2 and LT synthesis in both cell free and intact cell assays. Moreover, YS121 (1.5 kg/mg, intraperitoneal) ... mehr MW: 408 D Formula: C20H26ClN3O2S Purity: >98% |
Cayman |
25 mg |
873 €
|
| Cay13665-5 |
CAS: 916482-17-2 mPGES-1 / 5-LO inhibitor YS121 is a dual inhibitor of microsomal prostaglandin E2 synthase-1 (mPGES-1) (IC50 = 3.9 µM) and 5-LO (IC50 = 4.1 µM). It effectively inhibits PGE2 and LT synthesis in both cell free and intact cell assays. Moreover, YS121 (1.5 kg/mg, intraperitoneal) ... mehr MW: 408 D Formula: C20H26ClN3O2S Purity: >98% |
Cayman |
5 mg |
225 €
|
| Cay34215-0.05 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
50 µg |
78 €
|
| Cay34215-0.1 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
100 µg |
146 €
|
| Cay34215-0.5 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
500 µg |
650 €
|
| Cay36720-0.05 |
CAS: 92693-02-2 5-LO inhibitor 15(S)-HETrE is the hydroxy-trienoic acid resulting from 15-lipoxygenation of DGLA. It is an inhibitor of 5-LO in human PMNL with an IC50 value of 4.6 µM. In RBL cells, 15(S)-HETrE inhibits 5-LO, but is about 1/20 as potent as 15(S)-HpETE. MW: 322 D Formula: C20H34O3 Purity: >98% |
Cayman |
50 µg |
66 €
|
| Cay36720-0.1 |
CAS: 92693-02-2 5-LO inhibitor 15(S)-HETrE is the hydroxy-trienoic acid resulting from 15-lipoxygenation of DGLA. It is an inhibitor of 5-LO in human PMNL with an IC50 value of 4.6 µM. In RBL cells, 15(S)-HETrE inhibits 5-LO, but is about 1/20 as potent as 15(S)-HpETE. MW: 322 D Formula: C20H34O3 Purity: >98% |
Cayman |
100 µg |
125 €
|
| Cay36720-0.5 |
CAS: 92693-02-2 5-LO inhibitor 15(S)-HETrE is the hydroxy-trienoic acid resulting from 15-lipoxygenation of DGLA. It is an inhibitor of 5-LO in human PMNL with an IC50 value of 4.6 µM. In RBL cells, 15(S)-HETrE inhibits 5-LO, but is about 1/20 as potent as 15(S)-HpETE. MW: 322 D Formula: C20H34O3 Purity: >98% |
Cayman |
500 µg |
557 €
|
| Cay37720-0.05 |
CAS: 92693-04-4 5-LO inhibitor 15(S)-HEDE is produced from 11Z,14Z-eicosadienoic acid by 15-LO. 15(S)-HEDE is an inhibitor of RBL-1 cell 5-LO with an IC50 value of 26 µM. MW: 324 D Formula: C20H36O3 Purity: >98% |
Cayman |
50 µg |
199 €
|
| Cay37720-0.1 |
CAS: 92693-04-4 5-LO inhibitor 15(S)-HEDE is produced from 11Z,14Z-eicosadienoic acid by 15-LO. 15(S)-HEDE is an inhibitor of RBL-1 cell 5-LO with an IC50 value of 26 µM. MW: 324 D Formula: C20H36O3 Purity: >98% |
Cayman |
100 µg |
380 €
|
| Cay37720-0.25 |
CAS: 92693-04-4 5-LO inhibitor 15(S)-HEDE is produced from 11Z,14Z-eicosadienoic acid by 15-LO. 15(S)-HEDE is an inhibitor of RBL-1 cell 5-LO with an IC50 value of 26 µM. MW: 324 D Formula: C20H36O3 Purity: >98% |
Cayman |
250 µg |
844 €
|
| Cay37730-0.025 |
CAS: 105835-44-7 5-LO inhibitor 15-OxoEDE is produced by the oxidation of 15-HEDE. 15-OxoEDE inhibits 5-LO from RBL-1 cells with an IC50 of 55 µM, which is about 2-fold lower than 15(S)-HEDE. A related oxo-eicosanoid, 5-oxoETE, is biosynthesized from 5(S)-HETE by a specific dehydrogena ... mehr MW: 322 D Formula: C20H34O3 Purity: >95% |
Cayman |
25 µg |
60 €
|
| Cay37730-0.05 |
CAS: 105835-44-7 5-LO inhibitor 15-OxoEDE is produced by the oxidation of 15-HEDE. 15-OxoEDE inhibits 5-LO from RBL-1 cells with an IC50 of 55 µM, which is about 2-fold lower than 15(S)-HEDE. A related oxo-eicosanoid, 5-oxoETE, is biosynthesized from 5(S)-HETE by a specific dehydrogena ... mehr MW: 322 D Formula: C20H34O3 Purity: >95% |
Cayman |
50 µg |
115 €
|
| Cay37730-0.1 |
CAS: 105835-44-7 5-LO inhibitor 15-OxoEDE is produced by the oxidation of 15-HEDE. 15-OxoEDE inhibits 5-LO from RBL-1 cells with an IC50 of 55 µM, which is about 2-fold lower than 15(S)-HEDE. A related oxo-eicosanoid, 5-oxoETE, is biosynthesized from 5(S)-HETE by a specific dehydrogena ... mehr MW: 322 D Formula: C20H34O3 Purity: >95% |
Cayman |
100 µg |
217 €
|
| Cay37730-0.25 |
CAS: 105835-44-7 5-LO inhibitor 15-OxoEDE is produced by the oxidation of 15-HEDE. 15-OxoEDE inhibits 5-LO from RBL-1 cells with an IC50 of 55 µM, which is about 2-fold lower than 15(S)-HEDE. A related oxo-eicosanoid, 5-oxoETE, is biosynthesized from 5(S)-HETE by a specific dehydrogena ... mehr MW: 322 D Formula: C20H34O3 Purity: >95% |
Cayman |
250 µg |
483 €
|
| Cay70300-25000 |
CAS: 500-38-9 LO inhibitor NDGA is a non-selective lipoxygenase (LO) inhibitor which blocks cysteinyl leukotriene (CysLT) synthesis. MW: 302 D Formula: C18H22O4 Purity: >95% |
Cayman |
25 g |
731 €
|
| Cay70300-5000 |
CAS: 500-38-9 LO inhibitor NDGA is a non-selective lipoxygenase (LO) inhibitor which blocks cysteinyl leukotriene (CysLT) synthesis. MW: 302 D Formula: C18H22O4 Purity: >95% |
Cayman |
5 g |
199 €
|
| Cay70302-1 |
CAS: 24150-24-1 LO inhibitor Tetramethyl Nordihydroguaiaretic acid (TMNDGA) is a synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor. It induces growth arrest and apoptosis by suppressing Sp1-dependent Cdc2 and survivin gene expression. MW: 358 D Formula: C22H3O4 Purity: >95% |
Cayman |
1 g |
179 €
|
| Cay70302-500 |
CAS: 24150-24-1 LO inhibitor Tetramethyl Nordihydroguaiaretic acid (TMNDGA) is a synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor. It induces growth arrest and apoptosis by suppressing Sp1-dependent Cdc2 and survivin gene expression. MW: 358 D Formula: C22H3O4 Purity: >95% |
Cayman |
500 mg |
99 €
|
| Cay70530-100 |
CAS: 60940-34-3 COX inhibitor, LO inhibitor The glutathione peroxidase-like activity of ebselen inhibits cyclooxygenase and lipoxygenases at micromolar concentrations. MW: 274 D Formula: C13H9NOSe Purity: >99% |
Cayman |
100 mg |
292 €
|
| Cay70530-50 |
CAS: 60940-34-3 COX inhibitor, LO inhibitor The glutathione peroxidase-like activity of ebselen inhibits cyclooxygenase and lipoxygenases at micromolar concentrations. MW: 274 D Formula: C13H9NOSe Purity: >99% |
Cayman |
50 mg |
167 €
|
| Cay70600-10 |
CAS: 101910-24-1 5-LO inhibitor REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki value of 0.7 µM for guinea pig lung membranes. It is also an inhibitor of rat neutrophil 5-LO with an IC50 value of 0.12 µM. MW: 335 D Formula: C22H25NO2 Purity: >98% |
Cayman |
10 mg |
56 €
|
| Cay70600-100 |
CAS: 101910-24-1 5-LO inhibitor REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki value of 0.7 µM for guinea pig lung membranes. It is also an inhibitor of rat neutrophil 5-LO with an IC50 value of 0.12 µM. MW: 335 D Formula: C22H25NO2 Purity: >98% |
Cayman |
100 mg |
399 €
|
| Cay70600-5 |
CAS: 101910-24-1 5-LO inhibitor REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki value of 0.7 µM for guinea pig lung membranes. It is also an inhibitor of rat neutrophil 5-LO with an IC50 value of 0.12 µM. MW: 335 D Formula: C22H25NO2 Purity: >98% |
Cayman |
5 mg |
29 €
|
| Cay70600-50 |
CAS: 101910-24-1 5-LO inhibitor REV 5901 is an antagonist of cysteinyl-leukotriene receptors with a Ki value of 0.7 µM for guinea pig lung membranes. It is also an inhibitor of rat neutrophil 5-LO with an IC50 value of 0.12 µM. MW: 335 D Formula: C22H25NO2 Purity: >98% |
Cayman |
50 mg |
232 €
|
| Cay70602-10 |
CAS: 331-39-5 5-LO inhibitor Caffeic acid is an inhibitor of 5-LO with an IC50 value of 3.7-72 µM and 12-LO with an IC50 value of 5.1-30 µM. MW: 180 D Formula: C9H8O4 Purity: >97% |
Cayman |
10 g |
60 €
|
| Cay70602-25 |
CAS: 331-39-5 5-LO inhibitor Caffeic acid is an inhibitor of 5-LO with an IC50 value of 3.7-72 µM and 12-LO with an IC50 value of 5.1-30 µM. MW: 180 D Formula: C9H8O4 Purity: >97% |
Cayman |
25 g |
104 €
|
| Cay70602-5 |
CAS: 331-39-5 5-LO inhibitor Caffeic acid is an inhibitor of 5-LO with an IC50 value of 3.7-72 µM and 12-LO with an IC50 value of 5.1-30 µM. MW: 180 D Formula: C9H8O4 Purity: >97% |
Cayman |
5 g |
38 €
|
| Cay70635-10 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
10 mg |
399 €
|
| Cay70635-5 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
5 mg |
225 €
|
| Cay70635-50 |
CAS: 443919-96-8 COX-2 inhibitor, 5-LO inhibitor COX-2/5-LO inhibitors such as CAY10416 are apoptosis-inducing agents and are potentially useful in prostate cancer chemotherapy. MW: 536 D Formula: C29H29FN2O5S Purity: >95% |
Cayman |
50 mg |
1746 €
|
| Cay760700-96 |
Lipoxygenase Inhibitor Screening Assay Kit LO inhibitor screening Cayman's Lipoxygenase Inhibitor Screening Assay Kit detects and measures the hydroperoxides produced in the lipoxygenation reaction using a purified LO. The detection reaction is equally sensitive to hydroperoxides at various positions within the fatty ac ... mehr |
Cayman |
96 wells |
205 €
|
| Cay90200-1 |
CAS: 13488-22-7 LO inhibitor 5,8,11-ETI is a nonselective inhibitor of lipoxygenases. It inhibits 12-LO in human platelets with an ID50 value of 24 µM. MW: 300 D Formula: C20H28O2 Purity: >99% |
Cayman |
1 mg |
77 €
|
| Cay90200-10 |
CAS: 13488-22-7 LO inhibitor 5,8,11-ETI is a nonselective inhibitor of lipoxygenases. It inhibits 12-LO in human platelets with an ID50 value of 24 µM. MW: 300 D Formula: C20H28O2 Purity: >99% |
Cayman |
10 mg |
612 €
|
| Cay90200-5 |
CAS: 13488-22-7 LO inhibitor 5,8,11-ETI is a nonselective inhibitor of lipoxygenases. It inhibits 12-LO in human platelets with an ID50 value of 24 µM. MW: 300 D Formula: C20H28O2 Purity: >99% |
Cayman |
5 mg |
345 €
|
| Cay90200-50 |
CAS: 13488-22-7 LO inhibitor 5,8,11-ETI is a nonselective inhibitor of lipoxygenases. It inhibits 12-LO in human platelets with an ID50 value of 24 µM. MW: 300 D Formula: C20H28O2 Purity: >99% |
Cayman |
50 mg |
2680 €
|
| Cay90400-1 |
CAS: 2012-14-8 COX inhibitor, LO inhibitor Ro 3-1314 is an inhibitor of both COX and lipoxygenase. Ro 3-1314 inhibits ram seminal vesicle COX with a Ki of 0.6 µM.{1260} It is a more effective inhibitor of COX-1 than of 15-LO. MW: 276 D Formula: C18H28O2 Purity: >98% |
Cayman |
1 mg |
71 €
|
| Cay90400-10 |
CAS: 2012-14-8 COX inhibitor, LO inhibitor Ro 3-1314 is an inhibitor of both COX and lipoxygenase. Ro 3-1314 inhibits ram seminal vesicle COX with a Ki of 0.6 µM.{1260} It is a more effective inhibitor of COX-1 than of 15-LO. MW: 276 D Formula: C18H28O2 Purity: >98% |
Cayman |
10 mg |
566 €
|
| Cay90400-5 |
CAS: 2012-14-8 COX inhibitor, LO inhibitor Ro 3-1314 is an inhibitor of both COX and lipoxygenase. Ro 3-1314 inhibits ram seminal vesicle COX with a Ki of 0.6 µM.{1260} It is a more effective inhibitor of COX-1 than of 15-LO. MW: 276 D Formula: C18H28O2 Purity: >98% |
Cayman |
5 mg |
319 €
|
| Cay90400-50 |
CAS: 2012-14-8 COX inhibitor, LO inhibitor Ro 3-1314 is an inhibitor of both COX and lipoxygenase. Ro 3-1314 inhibits ram seminal vesicle COX with a Ki of 0.6 µM.{1260} It is a more effective inhibitor of COX-1 than of 15-LO. MW: 276 D Formula: C18H28O2 Purity: >98% |
Cayman |
50 mg |
2477 €
|